Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
The article presents a brief description of Аpremilast - the target synthetic anti-inflammatory drug, which is representative of a new class of agents for the treatment of psoriasis and psoriatic arthritis. The efficiency and safety of the new drug in the treatment of patients with severe psoriasis...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2019-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|